
InnoVations in MedTech

Breakthrough in Non-Invasive Diagnostics: Real-Time Pathogen & Disease Detection Using AI-Enhanced Raman Spectroscopy
· Our latest innovation in AI-powered diagnostics by eliminating invasive, slow, and costly methods. Traditional diagnostics rely on blood draws, biopsies, or swabs, which are painful, time-consuming, and resource-intensive.
- Our AI-powered, no-specimen diagnostic platform enables rapid, non-invasive, lab-free detection, providing instant, highly accurate point-of-care results—without the need for biological samples.
· Read more about our cutting-edge approach to diagnostics.
Our Inventions

No Specimen Viral Detector
- Shine laser on a finger
- Detect scattered light (Raman)
- Process Raman signal with machine learning
- Test results in seconds
- Environmentally friendly

Please Read our Peer-Reviewed Published Manuscript



Autonomous Infusion Device
Reduce IV Alarms by Automatically
- Change low volume bags
- Flush catheters
- Unkink tubing
- Aspirate air bubbles
- Charge low batteries


Meet the Team

Founder/CEO
Allen B Chefitz, MD
Surgeon/Scientist

Chief Operating Officer
Elisa Long, MD
MS in Computer Science, MIT

Scientific Advisor
Rohit Singh, PhD
Research Scientist at MIT and Expert in Machine Learning and Genomics

Consultant
Pyongwu Yang, PhD
Physical Chemistry, MIT, Optical Engineering
Patents
US Patent No. 11,872,708 “Monitoring and Maintaining an Intravenous Assembly Without Medical Staff Involvement For Safe Distancing Enforcement” Jan 16 2024
U.S. Patent No. 11,452,454 “Self Administered Non-Invasive Transcutaneous Viral Detector” Sept 27, 2022
U.S. Patent No. 11,304,605 “Self Administered Non-Invasive Transcutaneous Viral Detector” April 19, 2022
U.S. Patent No. 11,291,408 “Eyewear System For Detecting And Indicating Presence Of Coronavirus” April 5, 2022
U.S. Patent No. 10,906,180 “Monitoring And Maintaining An Intravenous Assembly Without Medical Staff involvement For Safe Distancing Enforcement” Feb. 2, 2021
Along with several Continuation Patents, Foreign Applications and Pending Patents.
